Abstract Introduction: This study aims to further characterize cannabidiol’s pharmacological and molecular profile as an antidepressant. Methods: Effects of cannabidiol…
Abstract The anxiolytic and antidepressant properties of cannabidiol (CBD) have been evaluated in several studies. However, the molecular mechanisms involved…
Abstract Drug treatments available for the management of substance use disorders (SUD) present multiple limitations in efficacy, lack of approved…
Abstract The potential therapeutic use of some Cannabis sativa plant compounds has been attracting great interest, especially for managing neuropsychiatric…
Abstract Nowadays, cannabis is the most consumed illicit drug. The global prevalence of the use of cannabis in 2017 was…
Abstract The high heterogeneity of psychiatric disorders leads to a lack of diagnostic precision. Therefore, the search of biomarkers is…